4.6 Article

Sevoflurane dose and postoperative delirium: a prospective cohort analysis

Journal

BRITISH JOURNAL OF ANAESTHESIA
Volume 130, Issue 2, Pages E289-E297

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.bja.2022.08.022

Keywords

anaesthesia; biomarker; cognitive dysfunction; delirium; dose dependency; postoperative; sevoflurane; surgery

Categories

Ask authors/readers for more resources

Recent trials have conflicting results on whether titration of anaesthetic dose using electroencephalography monitoring reduces postoperative delirium. This study aimed to clarify the dose ranges for trials of anaesthetic dose and the biological plausibility of anaesthetic dose influencing delirium by analyzing an observational cohort.
Background: Recent trials are conflicting as to whether titration of anaesthetic dose using electroencephalography monitoring reduces postoperative delirium. Titration to anaesthetic dose itself might yield clearer conclusions. We analysed our observational cohort to clarify both dose ranges for trials of anaesthetic dose and biological plausibility of anaesthetic dose influencing delirium. Methods: We analysed the use of sevoflurane in an ongoing prospective cohort of non-intracranial surgery. Of 167 participants, 118 received sevoflurane and were aged >65 yr. We tested associations between age-adjusted median sevoflurane (AMS) minimum alveolar concentration fraction or area under the sevoflurane timexdose curve (AUC-S) and delirium severity (Delirium Rating Scale-98). Delirium incidence was measured with 3-minute Diagnostic Confusion Assessment Method (3D-CAM) or CAM-ICU. Associations with previously identified delirium biomarkers (interleukin-8, neurofilament light, total tau, or S100B) were tested.Results: Delirium severity did not correlate with AMS (Spearman's r=-0.014, P=0.89) or AUC-S (r=0.093, P=0.35), nor did delirium incidence (AMS Wilcoxon P=0.86, AUC-S P=0.78). Further sensitivity analyses including propofol dose also demonstrated no relationship. Linear regression confirmed no association for AMS in unadjusted (log (IRR)=-0.06 P=0.645) or adjusted models (log (IRR)=-0.0454, P=0.735). No association was observed for AUC-S in unadjusted (log (IRR)=0.00, P=0.054) or adjusted models (log (IRR)=0.00, P=0.832). No association of anaesthetic dose with delirium bio-markers was identified (P>0.05).Conclusion: Sevoflurane dose was not associated with delirium severity or incidence. Other biological mechanisms of delirium, such as inflammation and neuronal injury, appear more plausible than dose of sevoflurane.Clinical trial registration: NCT03124303, NCT01980511.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available